Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshihiko Yanase

Showing results (1-10 of 203) with videos related to

Pageof 21
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 26, 2006
[Congenital adrenal hyperplasia causing hypertension]Toshihiko Yanase
Endocrine Journal|July 24, 2025
Recent progress in pathophysiology of cortisol-producing adrenal tumorToshihiko Yanase
Endocrine Journal|May 22, 2024
Reflections and expectations of an endocrinologist and diabetologist on the launch of a new, board-certified Endocrinology, Diabetes and Metabolism specialist system pioneered by the JES and the JDSToshihiko Yanase
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 17, 2003
[Clinical significance of dehydroepiandrosterone (DHEA) supplement therapy]Toshihiko Yanase
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 8, 2006
[Cell differentiation and regeneration of the adrenal glands]Toshihiko Yanase
Clinical Calcium|July 30, 2013
[Role of androgen in the elderly. Current status of development of selective androgen receptor modulator]Toshihiko Yanase
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 3, 2004
[Hypertension secondary to adrenal steroidogenic enzyme deficiency]Toshihiko Yanase
Internal Medicine (Tokyo, Japan)|March 10, 2004
Physiological significance of replacement therapy of dehydroepiandrosteroneToshihiko Yanase
Clinical Calcium|June 28, 2016
[A potential of selective androgen receptor modulator(SARM)for the therapy of osteoporosis]Toshihiko Yanase
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 10, 2005
[Cortisol, cortisone, urinary free cortisol]Toshihiko Yanase
Pageof 21

Showing results (1-10 of 203) with videos related to

Sort By:
Pageof 21
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 26, 2006
[Congenital adrenal hyperplasia causing hypertension]Toshihiko Yanase
Endocrine Journal|July 24, 2025
Recent progress in pathophysiology of cortisol-producing adrenal tumorToshihiko Yanase
Endocrine Journal|May 22, 2024
Reflections and expectations of an endocrinologist and diabetologist on the launch of a new, board-certified Endocrinology, Diabetes and Metabolism specialist system pioneered by the JES and the JDSToshihiko Yanase
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 17, 2003
[Clinical significance of dehydroepiandrosterone (DHEA) supplement therapy]Toshihiko Yanase
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 8, 2006
[Cell differentiation and regeneration of the adrenal glands]Toshihiko Yanase
Clinical Calcium|July 30, 2013
[Role of androgen in the elderly. Current status of development of selective androgen receptor modulator]Toshihiko Yanase
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 3, 2004
[Hypertension secondary to adrenal steroidogenic enzyme deficiency]Toshihiko Yanase
Internal Medicine (Tokyo, Japan)|March 10, 2004
Physiological significance of replacement therapy of dehydroepiandrosteroneToshihiko Yanase
Clinical Calcium|June 28, 2016
[A potential of selective androgen receptor modulator(SARM)for the therapy of osteoporosis]Toshihiko Yanase
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 10, 2005
[Cortisol, cortisone, urinary free cortisol]Toshihiko Yanase
Pageof 21